FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016642932> ?p ?o ?g. }

• W2016642932 endingPage "693" @default.
• W2016642932 startingPage "680" @default.
• W2016642932 abstract "Infiltration of the central nervous system (CNS) by CD4+ Th1 cells precedes onset and relapses of experimental autoimmune encephalomyelitis (EAE). We reported that (B6 × SJL) F1 (H-2b/s) mice with severe relapsing-remitting disease had extensive infiltration by CD4+ T cells compared to that in C57BL/6 (B6) (H-2b) mice, which developed mild low-relapsing disease in response to myelin oligodendrocyte peptide 35–55 (MOG35–55). This observation led us to search for mechanisms that specifically regulate trafficking of CD4+ cells in relapsing H-2b/s mice. We show that the CD4+ cell chemoattractant cytokine interleukin (IL)-16 has an important role in regulation of relapsing EAE induced by MOG35–55 in the (B6 × SJL) F1 (H-2b/s) mice. We found production of IL-16 in the CNS of mice with EAE. IL-16 levels in the CNS correlated well with the extent of CD4+ T-cell and B-cell infiltration during acute and relapsing disease. Infiltrating CD4+ T cells, B cells, and to a lesser extent CD8+ T cells all contained IL-16 immunoreactivity. Treatment with neutralizing anti-IL-16 antibody successfully reversed paralysis and ameliorated relapsing disease. In treated mice, diminished infiltration by CD4+ T cells, less demyelination, and more sparing of axons was observed. Taken together, our results show an important role for IL-16 in regulation of relapsing EAE. We describe a novel therapeutic approach to specifically impede CD4+ T cell chemoattraction in EAE based on IL-16 neutralization. Our findings have high relevance for the development of new therapies for relapsing EAE and potentially MS. © 2005 Wiley-Liss, Inc." @default.
• W2016642932 created "2016-06-24" @default.
• W2016642932 creator A5003711165 @default.
• W2016642932 creator A5035249454 @default.
• W2016642932 creator A5042044088 @default.
• W2016642932 creator A5057017150 @default.
• W2016642932 creator A5061976766 @default.
• W2016642932 creator A5073039503 @default.
• W2016642932 creator A5086200508 @default.
• W2016642932 date "2005-01-01" @default.
• W2016642932 modified "2023-10-03" @default.
• W2016642932 title "Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE" @default.
• W2016642932 cites W1491773178 @default.
• W2016642932 cites W1537824435 @default.
• W2016642932 cites W1801707244 @default.
• W2016642932 cites W1892477107 @default.
• W2016642932 cites W1906710068 @default.
• W2016642932 cites W1964500611 @default.
• W2016642932 cites W1966586109 @default.
• W2016642932 cites W1981997789 @default.
• W2016642932 cites W1984297626 @default.
• W2016642932 cites W1990056722 @default.
• W2016642932 cites W1991712316 @default.
• W2016642932 cites W2001467511 @default.
• W2016642932 cites W2008463971 @default.
• W2016642932 cites W2012855718 @default.
• W2016642932 cites W2015966937 @default.
• W2016642932 cites W2017605183 @default.
• W2016642932 cites W2023933035 @default.
• W2016642932 cites W2024081563 @default.
• W2016642932 cites W2026063970 @default.
• W2016642932 cites W2027935527 @default.
• W2016642932 cites W2028249636 @default.
• W2016642932 cites W2036523089 @default.
• W2016642932 cites W2041077164 @default.
• W2016642932 cites W2065612219 @default.
• W2016642932 cites W2071625815 @default.
• W2016642932 cites W2081421036 @default.
• W2016642932 cites W2098658552 @default.
• W2016642932 cites W2109098861 @default.
• W2016642932 cites W2118884692 @default.
• W2016642932 cites W2150062126 @default.
• W2016642932 cites W2155932192 @default.
• W2016642932 cites W2418248245 @default.
• W2016642932 cites W4243180424 @default.
• W2016642932 cites W4313347773 @default.
• W2016642932 doi "https://doi.org/10.1002/jnr.20377" @default.
• W2016642932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15682385" @default.
• W2016642932 hasPublicationYear "2005" @default.
• W2016642932 type Work @default.
• W2016642932 sameAs 2016642932 @default.
• W2016642932 citedByCount "40" @default.
• W2016642932 countsByYear W20166429322012 @default.
• W2016642932 countsByYear W20166429322013 @default.
• W2016642932 countsByYear W20166429322014 @default.
• W2016642932 countsByYear W20166429322015 @default.
• W2016642932 countsByYear W20166429322016 @default.
• W2016642932 countsByYear W20166429322018 @default.
• W2016642932 countsByYear W20166429322019 @default.
• W2016642932 countsByYear W20166429322021 @default.
• W2016642932 countsByYear W20166429322022 @default.
• W2016642932 countsByYear W20166429322023 @default.
• W2016642932 crossrefType "journal-article" @default.
• W2016642932 hasAuthorship W2016642932A5003711165 @default.
• W2016642932 hasAuthorship W2016642932A5035249454 @default.
• W2016642932 hasAuthorship W2016642932A5042044088 @default.
• W2016642932 hasAuthorship W2016642932A5057017150 @default.
• W2016642932 hasAuthorship W2016642932A5061976766 @default.
• W2016642932 hasAuthorship W2016642932A5073039503 @default.
• W2016642932 hasAuthorship W2016642932A5086200508 @default.
• W2016642932 hasConcept C121332964 @default.
• W2016642932 hasConcept C126322002 @default.
• W2016642932 hasConcept C142724271 @default.
• W2016642932 hasConcept C153400128 @default.
• W2016642932 hasConcept C167672396 @default.
• W2016642932 hasConcept C203014093 @default.
• W2016642932 hasConcept C2776090121 @default.
• W2016642932 hasConcept C2777899865 @default.
• W2016642932 hasConcept C2778486448 @default.
• W2016642932 hasConcept C2778609137 @default.
• W2016642932 hasConcept C2778690821 @default.
• W2016642932 hasConcept C2779357208 @default.
• W2016642932 hasConcept C2780640218 @default.
• W2016642932 hasConcept C47348012 @default.
• W2016642932 hasConcept C529278444 @default.
• W2016642932 hasConcept C71924100 @default.
• W2016642932 hasConcept C86803240 @default.
• W2016642932 hasConcept C8891405 @default.
• W2016642932 hasConcept C97355855 @default.
• W2016642932 hasConceptScore W2016642932C121332964 @default.
• W2016642932 hasConceptScore W2016642932C126322002 @default.
• W2016642932 hasConceptScore W2016642932C142724271 @default.
• W2016642932 hasConceptScore W2016642932C153400128 @default.
• W2016642932 hasConceptScore W2016642932C167672396 @default.
• W2016642932 hasConceptScore W2016642932C203014093 @default.
• W2016642932 hasConceptScore W2016642932C2776090121 @default.
• W2016642932 hasConceptScore W2016642932C2777899865 @default.
• W2016642932 hasConceptScore W2016642932C2778486448 @default.

• next